Australia as a global leader in clinical trials
Tracks
Concurrent Stream 1
Thursday, May 8, 2025 |
12:30 PM - 1:15 PM |
Pyrmont Theatre |
Details
This session will highlight why Australia is emerging as a global leader in clinical trials, exploring its competitive advantages, challenges, and the policies driving its success. With a robust healthcare system, well-established regulatory environment, and skilled workforce, Australia provides an ideal setting for high-quality clinical research. The country’s cost-effectiveness, fast patient recruitment, and adherence to international standards make it an attractive location for global pharmaceutical and Medtech companies.
Real-life examples of companies choosing Australia for clinical trials, such as those in the pharmaceutical and medical device sectors, will be discussed, demonstrating the country’s ability to manage complex trials efficiently. The session will also cover the challenges faced by the clinical trial industry, including policy changes, patient safety concerns, and the need for ethical oversight.
Attendees will gain valuable insights into how Australia’s strengths position it as a key player in global clinical research and innovation.
Speaker
Mr Lachlan Porter
Clinical Research Consultant
Clinico
Panellist
Ms Anne O'Neill
Director, Commercialisation and Strategic Partnerships
Office for Health and Medical Research, NSW Health
Chair
